Pharmacodynamics of high-dose methotrexate in pediatric patients

Annals of Pharmacotherapy

Volumn 36, Issue 9, 2002, Pages 1344-1350

  Aquerreta, Irene ^a   Aldaz, Azucena ^a   Giráldez, Joaquín ^a   Sierrasesúmaga, Luis ^a   Gagnon, Louise ^a  

^a Universidad Pública de Navarra   (Spain)

Author keywords

High dose methotrexate; Toxicity

Indexed keywords

METHOTREXATE; ANTINEOPLASTIC ANTIMETABOLITE;

ARTICLE; BLOOD TOXICITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ELIMINATION; DRUG MEGADOSE; FEMALE; HODGKIN DISEASE; HUMAN; LEUKOPENIA; LIVER TOXICITY; MALE; MUCOSA INFLAMMATION; NEPHROTOXICITY; OSTEOSARCOMA; PHARMACODYNAMICS; PRIORITY JOURNAL; VOMITING; ADOLESCENT; ADULT; ALGORITHM; AREA UNDER THE CURVE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEMATOLOGIC DISEASE; KIDNEY DISEASE; NEOPLASM; PATHOLOGY; PREDICTION AND FORECASTING; PRESCHOOL CHILD; STATISTICAL MODEL;

ADOLESCENT; ADULT; ALGORITHMS; ANTIMETABOLITES, ANTINEOPLASTIC; AREA UNDER CURVE; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEMATOLOGIC DISEASES; HUMANS; KIDNEY DISEASES; LINEAR MODELS; LOGISTIC MODELS; MALE; METHOTREXATE; NEOPLASMS; PREDICTIVE VALUE OF TESTS;

EID: 0036707858     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A446     Document Type: Article

References (33)

1. Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Analysis of the literature
2. The importance of doxorubicin and methotrexate dose intensity in the chemotherapy of osteosarcoma
3. Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect
4. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia
5. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)
6. The m-BACOD combination chemotherapy regimen in large lymphoma: Analysis of the completed trial and comparison with the M-BACOD regimen
7. Methotrexate
8. Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy
9. High-dose methotrexate: Pharmacokinetics in children and young adults
10. The safety of administration of massive doses of methotrexate (50 g) with equimolar citrovorum factor rescue in adult patients
11. Patient characteristics associated with high-risk methotrexate concentrations and toxicity
12. Oral mucositis in children with acute lymphoblastic leukemia after high-dose methotrexate treatment without delayed elimination of methotrexate: Relation to pharmacokinetic parameters of methotrexate
13. Monitoring of methotrexate and 7-hydroxymethotrexate in saliva from children with acute lymphoblastic leukemia receiving high-dose consolidation treatment: Relation to oral mucositis
14. Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia: A logistic regression analysis
15. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine
16. Reporting results of cancer treatment
17. Pharmacokinetics and toxicity of frequent intermediate dose methotrexate infusions
18. Carboxypeptidase-G2, thymidine and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction
19. Methotrexate-induced renal impairment: Clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine
20. Concepts in use of high-dose methotrexate therapy
21. The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: Impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg
22. Effect of gentamicin and irradiation on the toxicity of high-dose methotrexate in rats
23. Pharmacokinetics of methotrexate in Indian children and its relationship to nutritional status
24. Methotrexate pharmacokinetics and prognosis in osteosarcoma
25. Randomized study of high-dose versus low-dose methotrexate in the treatment of extensive small cell lung cancer
26. Central nervous system preventive therapy with systemic high-dose methotrexate versus cranial irradiation and intrathecal methotrexate: Longitudinal comparison of effects of treatment on intellectual function of children with ALL
27. 2 in children with acute lymphoblastic leukemia
28. Clinical pharmacokinetics of methotrexate in children